Deep Learning-Predicted Dihydroartemisinin Rescues Osteoporosis by Maintaining Mesenchymal Stem Cell Stemness through Activating Histone 3 Lys 9 Acetylation
Chemistry
QD1-999
3. Good health
DOI:
10.1021/acscentsci.3c00794
Publication Date:
2023-10-18T12:01:53Z
AUTHORS (18)
ABSTRACT
Maintaining the stemness of bone marrow mesenchymal stem cells (BMMSCs) is crucial for homeostasis and regeneration. However, in vitro expansion diseases impair BMMSC stemness, limiting its functionality tissue engineering. Using a deep learning-based efficacy prediction system sequencing, we identify natural small-molecule compound, dihydroartemisinin (DHA), that maintains enhances During long-term expansion, DHA preserves characteristics, including self-renewal ability unbiased differentiation. In an osteoporosis mouse model, oral administration restores femur trabecular structure, density, situ. Mechanistically, by promoting histone 3 lysine 9 acetylation via GCN5 activation both vivo vitro. Furthermore, bone-targeted delivery mesoporous silica nanoparticles improves therapeutic osteoporosis. Collectively, could be promising agent treating maintaining stemness.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (58)
CITATIONS (12)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....